
Hyperfine (HYPR) Stock Forecast & Price Target
Hyperfine (HYPR) Analyst Ratings
Bulls say
Hyperfine is attractive fundamentally because its AI-powered, portable ultra-low-field Swoop system solves a real access problem in brain imaging by delivering point-of-care MRI without specialized infrastructure or staff, while Model 2 and Optive AI materially improve signal, image quality, scan speed, patient comfort, and utilization. The commercial opportunity is supported by more than 200 systems deployed worldwide, roughly 250,000 images taken to date, a lean sales model, and a business structure that combines an upfront system sale of about $590K U.S. MSRP with recurring 5-year software, service, and support revenue of about $70K per year, which should improve margins and reduce cash burn over time. Demand catalysts also look strong across hospital, office, and international channels, with compelling 1–1.5 year hospital ROI, a newly opened office-based reimbursement pathway for the approximately 2,400 U.S. neurology office market, and guidance of $20M-$22M for FY26 backed by $43.5M in cash at the end of Q2, giving the company runway into 2028.
Bears say
Hyperfine is facing a fundamentally challenging setup because, despite management’s revenue growth narrative, 2Q26 revenue of $3.9M was below estimates, growth was flat sequentially, and the quarter’s higher international mix reduced ASPs, showing that demand quality and monetization remain uneven even as 12 units were placed. The company’s FY26 guide of $20M-$22M in revenue and $26M-$28M in cash burn still implies a business that is scaling from a very small base while remaining capital intensive, and that leaves it vulnerable to funding risk, potential dilution, and execution slippage if market conditions tighten or growth underwhelms. Hyperfine is also exposed to operational and strategic risks that are hard to control, including reliance on a limited supplier base with a single-source magnet provider, dependency on third-party manufacturing and international expansion, and the possibility that geopolitical or regulatory friction could slow adoption of its Swoop systems and compress margins.
This aggregate rating is based on analysts' research of Hyperfine and is not a guaranteed prediction by Public.com or investment advice.
Hyperfine (HYPR) Analyst Forecast & Price Prediction
Start investing in Hyperfine (HYPR)
Order type
Buy in
Order amount
Est. shares
0 shares